Lenvervimab

Modify Date: 2024-01-11 11:00:16

Lenvervimab structure	Common Name	Lenvervimab
	CAS Number	2055006-79-4	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Lenvervimab

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2].

Name	Lenvervimab

Description	Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV
In Vitro	Lenvervimab (1 nM-1 μM，16 小时) 抑制感染 HBV 的 HepG2-NTCP 细胞中的 HBV 感染[1]。 Lenvervimab 可识别 HBV 感染的许多病毒基因型和临床变异体[1]。 Western Blot Analysis[1] Cell Line: HepG2-NTCP cells infected with HBV Concentration: 1 nM-1 μM Incubation Time: 16 h Result: Inhibited viral expression of the surface antigen HBsAg (hepatitis B virus surface antigen) and the core protein HBcAg.
References	[1]. Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15(8):e0236704. [2]. Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18(13):3043-3045.e1.

No Any Chemical & Physical Properties